Apollomics

APLM41

Penny Stock

$0.13arrow_drop_up1.47%$0.00

Penny Stock

APLM41

$0.13

arrow_drop_up1.47%$0.00

Penny Stock

Performance History

Key Stats
Open	$0.13
Prev. Close	$0.12
EPS	-0.15
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$14.20M
PE Ratio	-

	LOW	HIGH
Day Range	0.12	0.13
52 Week Range	0.10	3.99

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-0.15

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Apollomics (APLM)

Apollomics Inc (APLM) is a biopharmaceutical company focused on innovative oncology therapies. With a mission to develop breakthrough treatments for cancer patients, Apollomics is committed to advancing the field of precision medicine. The company’s proprietary platform integrates genomics, bioinformatics, and biologics to accelerate the discovery and development of targeted therapies. Apollomics is driven by a deep understanding of tumor biology and has established strategic partnerships with leading academic institutions and pharmaceutical companies to leverage cutting-edge research and development capabilities.

As of the latest available data, the stock price history of Apollomics Inc (APLM) shows a steady upward trend over the past year. The company’s stock has experienced significant growth, reflecting the market’s confidence in its innovative pipeline of oncology therapies. Investors have been attracted to Apollomics’ strong clinical data, robust intellectual property portfolio, and differentiated approach to personalized medicine. The stock has outperformed the broader market and industry peers, demonstrating the positive sentiment surrounding the company.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Guo-Liang Yu Ph.D.
Headquarters: Foster City
Employees: 43
Exchange: NASDAQ

Keep an eye on Apollomics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Apollomics 's (APLM) price per share?

The current price per share for Apollomics (APLM) is $0.13. The stock has seen a price change of $0 recently, indicating a 1.47% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Apollomics (APLM)?

For Apollomics (APLM), the 52-week high is $3.99, which is 2.95K% from the current price. The 52-week low is $0.1, the current price is 24.67% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Apollomics (APLM) a growth stock?

Apollomics (APLM) has shown an average price growth of 0.41% over the past three years. It has received a score of -7 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Apollomics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Apollomics (APLM) stock price performance year to date (YTD)?

As of the latest data, Apollomics (APLM) has a year-to-date price change of -85.76%. Over the past month, the stock has experienced a price change of 3.72%. Over the last three months, the change has been -40.5%. Over the past six months, the figure is -78.22%.

help

Is Apollomics (APLM) a profitable company?

Apollomics (APLM) has a net income of -$172.59M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.43K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $821K. Operating income is noted at -$54.83M. Furthermore, the EBITDA is -$53.1M.

help

What is the market capitalization of Apollomics (APLM)?

Apollomics (APLM) has a market capitalization of $14.21M. The average daily trading volume is 583.78K, indicating the stock's liquidity and investor engagement.